APO Research
Talk to an analyst

APO RESEARCH · REPORT

Renal Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Renal Drugs Market Analysis and Forecast 2026-2032

19 December 2025192 pages

Choose your research edition.

Industry ResearchRenal Drugs Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Renal Drugs Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Renal Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Renal Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Renal Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Renal Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Renal Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Renal Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Renal Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Renal Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Renal Drugs include Mylan, Roche Holding, Fresenius, Endo International, Dava Pharmaceuticals, Cardinal Health, Bausch Health Companies and Apotex, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Renal Drugs, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Renal Drugs, also provides the revenue of main regions and countries. Of the upcoming market potential for Renal Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Renal Drugs revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Renal Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Renal Drugs revenue, projected growth trends, production technology, application and end-user industry.

Renal Drugs Segment by Company

Mylan

Roche Holding

Fresenius

Endo International

Dava Pharmaceuticals

Cardinal Health

Bausch Health Companies

Apotex

Renal Drugs Segment by Type

Oral

Injections

Renal Drugs Segment by Application

Hospital Pharmacy

Drug Stores

Online Pharmacy

Retail Pharmacies

Others

Renal Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Renal Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Renal Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Renal Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Renal Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Renal Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Renal Drugs revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Renal Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Major Player Table 3. Injections Major Player Table 4. Global Renal Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Pharmacy Major Player Table 6. Drug Stores Major Player Table 7. Online Pharmacy Major Player Table 8. Retail Pharmacies Major Player Table 9. Others Major Player Table 10. Renal Drugs Industry Trends Table 11. Renal Drugs Industry Drivers Table 12. Renal Drugs Industry Opportunities and Challenges Table 13. Renal Drugs Industry Restraints Table 14. Global Renal Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Renal Drugs Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Renal Drugs Market Share by Region (2021-2026) Table 17. Global Renal Drugs Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Renal Drugs Market Share by Region (2027-2032) Table 19. Global Renal Drugs Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Renal Drugs Revenue Market Share by Players (2021-2026) Table 21. Global Renal Drugs Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Renal Drugs Key Players Headquarters & Area Served Table 23. Global Renal Drugs Players, Product Type & Application Table 24. Global Renal Drugs Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Renal Drugs by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Renal Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Renal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Renal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Renal Drugs Revenue Market Share by Type (2021-2026) Table 31. Global Renal Drugs Revenue Market Share by Type (2027-2032) Table 32. Global Renal Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Renal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Renal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Renal Drugs Revenue Market Share by Application (2021-2026) Table 36. Global Renal Drugs Revenue Market Share by Application (2027-2032) Table 37. Mylan Company Information Table 38. Mylan Business Overview Table 39. Mylan Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Mylan Renal Drugs Product Portfolio Table 41. Mylan Recent Development Table 42. Roche Holding Company Information Table 43. Roche Holding Business Overview Table 44. Roche Holding Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Roche Holding Renal Drugs Product Portfolio Table 46. Roche Holding Recent Development Table 47. Fresenius Company Information Table 48. Fresenius Business Overview Table 49. Fresenius Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Fresenius Renal Drugs Product Portfolio Table 51. Fresenius Recent Development Table 52. Endo International Company Information Table 53. Endo International Business Overview Table 54. Endo International Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Endo International Renal Drugs Product Portfolio Table 56. Endo International Recent Development Table 57. Dava Pharmaceuticals Company Information Table 58. Dava Pharmaceuticals Business Overview Table 59. Dava Pharmaceuticals Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Dava Pharmaceuticals Renal Drugs Product Portfolio Table 61. Dava Pharmaceuticals Recent Development Table 62. Cardinal Health Company Information Table 63. Cardinal Health Business Overview Table 64. Cardinal Health Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Cardinal Health Renal Drugs Product Portfolio Table 66. Cardinal Health Recent Development Table 67. Bausch Health Companies Company Information Table 68. Bausch Health Companies Business Overview Table 69. Bausch Health Companies Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Bausch Health Companies Renal Drugs Product Portfolio Table 71. Bausch Health Companies Recent Development Table 72. Apotex Company Information Table 73. Apotex Business Overview Table 74. Apotex Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Apotex Renal Drugs Product Portfolio Table 76. Apotex Recent Development Table 77. North America Renal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 78. North America Renal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 79. North America Renal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 80. North America Renal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 81. North America Renal Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. North America Renal Drugs Revenue by Country (2021-2026) & (US$ Million) Table 83. North America Renal Drugs Revenue by Country (US$ Million) & (2027-2032) Table 84. Europe Renal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 85. Europe Renal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 86. Europe Renal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 87. Europe Renal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 88. Europe Renal Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. Europe Renal Drugs Revenue by Country (2021-2026) & (US$ Million) Table 90. Europe Renal Drugs Revenue by Country (US$ Million) & (2027-2032) Table 91. China Renal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 92. China Renal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 93. China Renal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 94. China Renal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 95. Asia Renal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 96. Asia Renal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 97. Asia Renal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 98. Asia Renal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 99. Asia Renal Drugs Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 100. Asia Renal Drugs Revenue by Region (US$ Million) & (2021-2026) Table 101. Asia Renal Drugs Revenue by Region (US$ Million) & (2027-2032) Table 102. SAMEA Renal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 103. SAMEA Renal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 104. SAMEA Renal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 105. SAMEA Renal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 106. SAMEA Renal Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. SAMEA Renal Drugs Revenue by Country (2021-2026) & (US$ Million) Table 108. SAMEA Renal Drugs Revenue by Country (US$ Million) & (2027-2032) Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Renal Drugs Image Figure 2. Global Renal Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Renal Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Image Figure 5. Injections Image Figure 6. Global Renal Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Renal Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Pharmacy Image Figure 9. Drug Stores Image Figure 10. Online Pharmacy Image Figure 11. Retail Pharmacies Image Figure 12. Others Image Figure 13. Global Renal Drugs Market Size (US$ Million) & (2021-2032) Figure 14. Global Renal Drugs Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Renal Drugs Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Renal Drugs Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Renal Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Renal Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Renal Drugs Revenue Market Share by Type (2021-2032) Figure 21. Global Renal Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Renal Drugs Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Renal Drugs Revenue Market Share by Application (2021-2032) Figure 24. North America Renal Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Renal Drugs Revenue Share by Type (2021-2032) Figure 26. North America Renal Drugs Revenue Share by Application (2021-2032) Figure 27. North America Renal Drugs Revenue Share by Country (2021-2032) Figure 28. United States Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Renal Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Renal Drugs Revenue Share by Type (2021-2032) Figure 33. Europe Renal Drugs Revenue Share by Application (2021-2032) Figure 34. Europe Renal Drugs Revenue Share by Country (2021-2032) Figure 35. Germany Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Renal Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Renal Drugs Revenue Share by Type (2021-2032) Figure 45. China Renal Drugs Revenue Share by Application (2021-2032) Figure 46. Asia Renal Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Renal Drugs Revenue Share by Type (2021-2032) Figure 48. Asia Renal Drugs Revenue Share by Application (2021-2032) Figure 49. Asia Renal Drugs Revenue Share by Region (2021-2032) Figure 50. Japan Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Renal Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Renal Drugs Revenue Share by Type (2021-2032) Figure 58. SAMEA Renal Drugs Revenue Share by Application (2021-2032) Figure 59. SAMEA Renal Drugs Revenue Share by Country (2021-2032) Figure 60. Brazil Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Renal Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injections
Applications
  • Hospital Pharmacy
  • Drug Stores
  • Online Pharmacy
  • Retail Pharmacies
  • Others
Companies covered
  • Mylan
  • Roche Holding
  • Fresenius
  • Endo International
  • Dava Pharmaceuticals
  • Cardinal Health
  • Bausch Health Companies
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Renal Drugs Market by Type
  3. 1.2.1 Global Renal Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral
  5. 1.2.3 Injections
  6. 1.3 Renal Drugs Market by Application
  7. 1.3.1 Global Renal Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital Pharmacy
  9. 1.3.3 Drug Stores
  10. 1.3.4 Online Pharmacy
  11. 1.3.5 Retail Pharmacies
  12. 1.3.6 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Renal Drugs Market Dynamics
  1. 2.1 Renal Drugs Industry Trends
  2. 2.2 Renal Drugs Industry Drivers
  3. 2.3 Renal Drugs Industry Opportunities and Challenges
  4. 2.4 Renal Drugs Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Renal Drugs Market Perspective (2021-2032)
  2. 3.2 Global Renal Drugs Growth Trends by Region
  3. 3.2.1 Global Renal Drugs Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Renal Drugs Market Size by Region (2021-2026)
  5. 3.2.3 Global Renal Drugs Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Renal Drugs Revenue by Players
  2. 4.1.1 Global Renal Drugs Revenue by Players (2021-2026)
  3. 4.1.2 Global Renal Drugs Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Renal Drugs Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Renal Drugs Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Renal Drugs Key Players Headquarters & Area Served
  7. 4.4 Global Renal Drugs Players, Product Type & Application
  8. 4.5 Global Renal Drugs Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Renal Drugs Market CR5 and HHI
  11. 4.6.3 2025 Renal Drugs Tier 1, Tier 2, and Tier 3
5 Renal Drugs Market Size by Type
  1. 5.1 Global Renal Drugs Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Renal Drugs Revenue by Type (2021-2032)
  3. 5.3 Global Renal Drugs Revenue Market Share by Type (2021-2032)
6 Renal Drugs Market Size by Application
  1. 6.1 Global Renal Drugs Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Renal Drugs Revenue by Application (2021-2032)
  3. 6.3 Global Renal Drugs Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Mylan
  2. 7.1.1 Mylan Company Information
  3. 7.1.2 Mylan Business Overview
  4. 7.1.3 Mylan Renal Drugs Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Mylan Renal Drugs Product Portfolio
  6. 7.1.5 Mylan Recent Developments
  7. 7.2 Roche Holding
  8. 7.2.1 Roche Holding Company Information
  9. 7.2.2 Roche Holding Business Overview
  10. 7.2.3 Roche Holding Renal Drugs Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Roche Holding Renal Drugs Product Portfolio
  12. 7.2.5 Roche Holding Recent Developments
  13. 7.3 Fresenius
  14. 7.3.1 Fresenius Company Information
  15. 7.3.2 Fresenius Business Overview
  16. 7.3.3 Fresenius Renal Drugs Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Fresenius Renal Drugs Product Portfolio
  18. 7.3.5 Fresenius Recent Developments
  19. 7.4 Endo International
  20. 7.4.1 Endo International Company Information
  21. 7.4.2 Endo International Business Overview
  22. 7.4.3 Endo International Renal Drugs Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Endo International Renal Drugs Product Portfolio
  24. 7.4.5 Endo International Recent Developments
  25. 7.5 Dava Pharmaceuticals
  26. 7.5.1 Dava Pharmaceuticals Company Information
  27. 7.5.2 Dava Pharmaceuticals Business Overview
  28. 7.5.3 Dava Pharmaceuticals Renal Drugs Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Dava Pharmaceuticals Renal Drugs Product Portfolio
  30. 7.5.5 Dava Pharmaceuticals Recent Developments
  31. 7.6 Cardinal Health
  32. 7.6.1 Cardinal Health Company Information
  33. 7.6.2 Cardinal Health Business Overview
  34. 7.6.3 Cardinal Health Renal Drugs Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Cardinal Health Renal Drugs Product Portfolio
  36. 7.6.5 Cardinal Health Recent Developments
  37. 7.7 Bausch Health Companies
  38. 7.7.1 Bausch Health Companies Company Information
  39. 7.7.2 Bausch Health Companies Business Overview
  40. 7.7.3 Bausch Health Companies Renal Drugs Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Bausch Health Companies Renal Drugs Product Portfolio
  42. 7.7.5 Bausch Health Companies Recent Developments
  43. 7.8 Apotex
  44. 7.8.1 Apotex Company Information
  45. 7.8.2 Apotex Business Overview
  46. 7.8.3 Apotex Renal Drugs Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Apotex Renal Drugs Product Portfolio
  48. 7.8.5 Apotex Recent Developments
8 North America
  1. 8.1 North America Renal Drugs Revenue (2021-2032)
  2. 8.2 North America Renal Drugs Revenue by Type (2021-2032)
  3. 8.2.1 North America Renal Drugs Revenue by Type (2021-2026)
  4. 8.2.2 North America Renal Drugs Revenue by Type (2027-2032)
  5. 8.3 North America Renal Drugs Revenue Share by Type (2021-2032)
  6. 8.4 North America Renal Drugs Revenue by Application (2021-2032)
  7. 8.4.1 North America Renal Drugs Revenue by Application (2021-2026)
  8. 8.4.2 North America Renal Drugs Revenue by Application (2027-2032)
  9. 8.5 North America Renal Drugs Revenue Share by Application (2021-2032)
  10. 8.6 North America Renal Drugs Revenue by Country
  11. 8.6.1 North America Renal Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Renal Drugs Revenue by Country (2021-2026)
  13. 8.6.3 North America Renal Drugs Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Renal Drugs Revenue (2021-2032)
  2. 9.2 Europe Renal Drugs Revenue by Type (2021-2032)
  3. 9.2.1 Europe Renal Drugs Revenue by Type (2021-2026)
  4. 9.2.2 Europe Renal Drugs Revenue by Type (2027-2032)
  5. 9.3 Europe Renal Drugs Revenue Share by Type (2021-2032)
  6. 9.4 Europe Renal Drugs Revenue by Application (2021-2032)
  7. 9.4.1 Europe Renal Drugs Revenue by Application (2021-2026)
  8. 9.4.2 Europe Renal Drugs Revenue by Application (2027-2032)
  9. 9.5 Europe Renal Drugs Revenue Share by Application (2021-2032)
  10. 9.6 Europe Renal Drugs Revenue by Country
  11. 9.6.1 Europe Renal Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Renal Drugs Revenue by Country (2021-2026)
  13. 9.6.3 Europe Renal Drugs Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Renal Drugs Revenue (2021-2032)
  2. 10.2 China Renal Drugs Revenue by Type (2021-2032)
  3. 10.2.1 China Renal Drugs Revenue by Type (2021-2026)
  4. 10.2.2 China Renal Drugs Revenue by Type (2027-2032)
  5. 10.3 China Renal Drugs Revenue Share by Type (2021-2032)
  6. 10.4 China Renal Drugs Revenue by Application (2021-2032)
  7. 10.4.1 China Renal Drugs Revenue by Application (2021-2026)
  8. 10.4.2 China Renal Drugs Revenue by Application (2027-2032)
  9. 10.5 China Renal Drugs Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Renal Drugs Revenue (2021-2032)
  2. 11.2 Asia Renal Drugs Revenue by Type (2021-2032)
  3. 11.2.1 Asia Renal Drugs Revenue by Type (2021-2026)
  4. 11.2.2 Asia Renal Drugs Revenue by Type (2027-2032)
  5. 11.3 Asia Renal Drugs Revenue Share by Type (2021-2032)
  6. 11.4 Asia Renal Drugs Revenue by Application (2021-2032)
  7. 11.4.1 Asia Renal Drugs Revenue by Application (2021-2026)
  8. 11.4.2 Asia Renal Drugs Revenue by Application (2027-2032)
  9. 11.5 Asia Renal Drugs Revenue Share by Application (2021-2032)
  10. 11.6 Asia Renal Drugs Revenue by Country
  11. 11.6.1 Asia Renal Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Renal Drugs Revenue by Country (2021-2026)
  13. 11.6.3 Asia Renal Drugs Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Renal Drugs Revenue (2021-2032)
  2. 12.2 SAMEA Renal Drugs Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Renal Drugs Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Renal Drugs Revenue by Type (2027-2032)
  5. 12.3 SAMEA Renal Drugs Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Renal Drugs Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Renal Drugs Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Renal Drugs Revenue by Application (2027-2032)
  9. 12.5 SAMEA Renal Drugs Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Renal Drugs Revenue by Country
  11. 12.6.1 SAMEA Renal Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Renal Drugs Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Renal Drugs Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst